日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development

社论:药物研发过程中抗肿瘤单克隆抗体开发中的安全性考量

Wang, Tao; Abedin, Shaad Essa; van der Laan, Jan Willem

Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors

接受PD-L1抑制剂治疗的铂类化疗后转移性尿路上皮癌患者生存的五因素预后模型

Sonpavde, Guru; Manitz, Juliane; Gao, Chen; Tayama, Darren; Kaiser, Constanze; Hennessy, Daniel; Makari, Doris; Gupta, Ashok; Abdullah, Shaad Essa; Niegisch, Guenter; Rosenberg, Jonathan E; Bajorin, Dean F; Grivas, Petros; Apolo, Andrea B; Dreicer, Robert; Hahn, Noah M; Galsky, Matthew D; Necchi, Andrea; Srinivas, Sandy; Powles, Thomas; Choueiri, Toni K; Pond, Gregory R